Internal Medicine, Cardiovascular Disease · Los Angeles, CA
NPI
1003914227
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6333 Wilshire Blvd Ste 200
Los Angeles, CA, 90048
Phone (323) 653-2504
Groups this clinician bills Medicare through
Medicare paid, 2024
$710K
10,952 services
Medicare patients, 2024
793
Average age 79
Drug cost, 2024
$7.8M
34,680 prescriptions
Company payments, 2025
$3,205
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Milstein was code 99215 (office e&m - established), 1,534 times for 662 patients. In total Anna Milstein billed 10,952 services in 74 codes, and Medicare paid $710K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,534 | 662 | $154.94 | $238K |
| 36415 Venipuncture Blood Collection | Office | 1,069 | 508 | $8.65 | $9,247 |
| 99212 Office E&M - Established | Office | 856 | 322 | $48.91 | $42K |
| 93000 Electrocardiogram | Office | 728 | 515 | $12.26 | $8,922 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 565 | 565 | $21.29 | $12K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 538 | 538 | $20.66 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 514 | 490 | $177.50 | $91K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 504 | 504 | $27.06 | $14K |
| 99442 Telephone Services | Office | 376 | 256 | $77.76 | $29K |
| 96372 Injection Administration | Office | 352 | 86 | $12.71 | $4,474 |
| 99214 Office E&M - Established | Office | 327 | 240 | $109.83 | $36K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 282 | 231 | $27.11 | $7,645 |
| 96375 Injection Administration | Office | 246 | 36 | $13.94 | $3,429 |
| 96374 Injection Administration | Office | 246 | 36 | $33.61 | $8,269 |
| 96365 Intravenous Infusion, Hydration | Office | 245 | 36 | $57.77 | $14K |
By year: 2022 $592K for 9,268 services; 2023 $588K for 9,358 services; 2024 $710K for 10,952 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,069 | 508 | $8.65 | $9,247 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Milstein prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 1,409 prescriptions and refills. In total Anna Milstein wrote 34,680 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 1,409 | 1,496 | 156 | $983K |
| Rosuvastatin Calcium Generic | 1,018 | 1,184 | 123 | $3,958 |
| Xarelto Rivaroxaban | 959 | 1,023 | 104 | $573K |
| Furosemide Generic | 927 | 967 | 105 | $1,302 |
| Synthroid Levothyroxine Sodium | 909 | 1,038 | 104 | $47K |
| Metoprolol Succinate Generic | 901 | 990 | 98 | $5,722 |
| Carvedilol Generic | 830 | 931 | 95 | $1,885 |
| Atorvastatin Calcium Generic | 797 | 972 | 102 | $3,010 |
| Vascepa Icosapent Ethyl | 761 | 769 | 96 | $269K |
| Olmesartan Medoxomil Generic | 683 | 782 | 82 | $4,547 |
| Nebivolol Hcl Generic | 671 | 724 | 64 | $24K |
| Amlodipine Besylate Generic | 608 | 737 | 81 | $1,184 |
| Farxiga Dapagliflozin Propanediol | 605 | 657 | 84 | $363K |
| Potassium Chloride Generic | 584 | 590 | 58 | $17K |
| Pitavastatin Calcium Generic | 582 | 669 | 77 | $123K |
Brand drugs: 11,891 claims; generic drugs: 22,679 claims; opioid claims: 203.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Milstein $3,205 ($3,205 in general payments such as food, travel and fees) from 24 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $370.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 20 | $370 |
| Amgen Inc. AMGN | 16 | $294 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $292 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $220 |
| Pfizer Inc. PFE | 6 | $193 |
| Abbvie Inc. ABBV | 8 | $188 |
| Radius Health, Inc. | 7 | $181 |
| Esperion Therapeutics, Inc. ESPR | 11 | $163 |
| Merck Sharp & Dohme LLC MRK | 5 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.